We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-29.00 | -1.60% | 1,783.50 | 1,779.50 | 1,780.50 | 1,802.00 | 1,775.50 | 1,792.50 | 5,323,517 | 16:35:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.87 | 73.28B |
TIDMGSK
RNS Number : 0214N
GSK PLC
17 January 2023
GSK plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Ms E Walmsley ==== ====================================== ====================================================== b) Position/status Chief Executive Officer ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 577 ======================================================================= ====================== GBP14.3100 480 ======================================================================= ====================== GBP14.3100 719 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 1,776 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr I Mackay ==== ====================================== ====================================================== b) Position/status Chief Financial Officer ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 390 ======================================================================= ====================== GBP14.3100 333 ======================================================================= ====================== GBP14.3100 497 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 1,220 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Dr H Barron ==== ======================================== ==================================================== b) Position/status Non-Executive Director ==== ======================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ======================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of American Depositary Shares ('ADSs') the financial instrument ISIN: US37733W2044 ==== ======================================== ==================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 12 January 2023 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ====================== ========================= $35.1500 326 ====================== ========================= $35.1500 247 ====================== ========================= $35.1500 390 ====================== ========================= d) Aggregated information ==== Aggregated volume 963 Price $35.1500 ================================================================================================== e) Date of the transaction 2023-01-16 ==== ======================================== ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Ms D Conrad ==== ====================================== ====================================================== b) Position/status Chief People Officer ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 75 ======================================================================= ====================== GBP14.3100 69 ======================================================================= ====================== GBP14.3100 112 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 256 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr J Ford ==== ====================================== ====================================================== b) Position/status SVP and Group General Counsel, Legal and Compliance ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 107 ======================================================================= ====================== GBP14.3100 83 ======================================================================= ====================== GBP14.3100 139 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 329 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Ms S Jackson ==== ====================================== ====================================================== b) Position/status SVP, Global Communications and CEO Office ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 45 ======================================================================= ====================== GBP14.3100 42 ======================================================================= ====================== GBP14.3100 64 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 151 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr L Miels ==== ====================================== ====================================================== b) Position/status Chief Commercial Officer ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 174 ======================================================================= ====================== GBP14.3100 130 ======================================================================= ====================== GBP14.3100 236 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 540 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Ms S Ramakrishnan ==== ======================================== ==================================================== b) Position/status Chief Digital and Technology Officer ==== ======================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ======================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of American Depositary Shares ('ADSs') the financial instrument ISIN: US37733W2044 ==== ======================================== ==================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 12 January 2023 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================== ====================== ========================= $35.1500 23 ====================== ========================= d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ========================================= ======================================================== e) Date of the transaction 2023-01-16 ==== ======================================== ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr D Redfern ==== ====================================== ======================================================
b) Position/status President Corporate Development ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 128 ======================================================================= ====================== GBP14.3100 102 ======================================================================= ====================== GBP14.3100 156 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 386 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr R Simard ==== ====================================== ====================================================== b) Position/status President, Global Supply Chain ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 90 ======================================================================= ====================== GBP14.3100 77 ======================================================================= ====================== GBP14.3100 142 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 309 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr P Thomson ==== ====================================== ====================================================== b) Position/status President, Global Affairs ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 74 ======================================================================= ======================
GBP14.3100 59 ======================================================================= ====================== GBP14.3100 98 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 231 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Ms D Waterhouse ==== ====================================== ====================================================== b) Position/status CEO, ViiV Healthcare ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.3100 123 ======================================================================= ====================== GBP14.3100 104 ======================================================================= ====================== d) Aggregated information ==== Aggregated volume 227 Price GBP14.3100 ====================================== =========================================================== e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ========================================================================== a) Name Ms E Walmsley === ======================== ================================================ b) Position/status Chief Executive Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GSK plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 === ======================== ================================================ b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Performance Share Plan subject to a 2-year holding period === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) ---------- GBP14.3100 6,304.099 ---------- === ======================== ================================================ d) Aggregated information N/A (single transaction) Aggregated volume Price === ======================== ================================================ e) Date of the transaction 2023-01-16 === ======================== ================================================ f) Place of the London Stock Exchange (XLON) transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr I Mackay ==== ====================================== ====================================================== b) Position/status Chief Financial Officer ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GSK plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary the financial Shares') instrument ISIN: GB00BN7SWP63 ==== ====================================== ====================================================== b) Nature of the Acquisition of Ordinary Shares following transaction the re-investment of dividends paid to shareholders on 12 January 2023 on Ordinary Shares held in the Company's Performance Share Plan subject to a 2-year holding period ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ======================
GBP14.3100 1,517.833 ======================================================================= ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ==================================================================== ============================= e) Date of the transaction 2023-01-16 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ======================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSFIFLWEDSEDF
(END) Dow Jones Newswires
January 17, 2023 10:30 ET (15:30 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions